Searchable abstracts of presentations at key conferences in endocrinology

ea0062p24 | Poster Presentations | EU2019

First paraganglioma identified on surveillance screening in an asymptomatic SDHA germline mutation carrier

White Gemma , Tufton Nicola , Adams Ashok , Akker Scott

Case history: We present the case of a 72-year-old female who was referred to the endocrinology service following the identification of a pathogenic germline mutation in the SDHA gene (c.91C>T, p.Arg32*) as part of a genetic panel for hypertrophic cardiomyopathy. There was no personal or family history of phaeochromocytoma or paraganglioma (PPGL), gastrointestinal stromal tumours or pituitary adenoma.Investigations: Our patient was reviewed ...

ea0070ep542 | Hot topics (including COVID-19) | ECE2020

COVID-19 infection in a patient with life-treatening hypercalcaemia and sickle cell disease

Seguna Desiree , Marshall Henry , Barroso Filipa , Parvanta Laila , Adams Ashok , Berney Daniel , Akker Scott , Cavlan Dominic

A 21-year-old woman with homozygous sickle cell disease, presented to A&E with vomiting and diarrhoea, and was noted to be hypercalcaemic (corrected calcium 3.00 mmol/l [ref. 2.2–2.6]; phosphate 0.48 mmol/l [ref. 0.8–1.5]). She reported polyuria and polydipsia, but no other symptoms of hypercalcaemia. There was no history of renal stones, renal impairment, or fragility fracture. A maternal aunt required parathyroidectomy in middle age. Bloods revealed PTH 138.4 pmo...

ea0050p401 | Thyroid | SFEBES2017

Does presence of ‘Coexisting Thyroiditis’ affect Radioiodine Uptake in Thyroid Cancer Ablation Doses?

Shah Shanty George , Waterhouse Mona , Akker Scott , Drake William , Plowman Nick , Berney Daniel M , Richards Polly , Adams Ashok , Nowosinska Ewa , Brennan Carmel , Druce Maralyn

Background: Patients being treated for differentiated thyroid cancer (DTC) receive a dose of Radioiodine for remnant ablation. Occasional patients appear to have little or no iodine uptake at all in the thyroid bed or else where even shortly after thyroidectomy.Objective: To evaluate the influence of ‘Coexisting Thyroiditis’ on radioiodine uptake in thyroid cancer ablation doses.Methods and Design: Retrospec...

ea0050p401 | Thyroid | SFEBES2017

Does presence of ‘Coexisting Thyroiditis’ affect Radioiodine Uptake in Thyroid Cancer Ablation Doses?

Shah Shanty George , Waterhouse Mona , Akker Scott , Drake William , Plowman Nick , Berney Daniel M , Richards Polly , Adams Ashok , Nowosinska Ewa , Brennan Carmel , Druce Maralyn

Background: Patients being treated for differentiated thyroid cancer (DTC) receive a dose of Radioiodine for remnant ablation. Occasional patients appear to have little or no iodine uptake at all in the thyroid bed or else where even shortly after thyroidectomy.Objective: To evaluate the influence of ‘Coexisting Thyroiditis’ on radioiodine uptake in thyroid cancer ablation doses.Methods and Design: Retrospec...